Michael Vala, PharmD
Michael Vala, PharmD, is a PGY-2 infectious diseases pharmacy resident at Beth Israel Deaconess Medical Center in Boston, Massachusetts, who is interested in transplant infectious diseases and mycobacterial infections.
Articles
Do We Have New Data for Optimal Treatments of Candida-Related Prosthetic Joint Infections?
January 14th 2025The choice between debridement and implant exchange affects treatment outcomes for Candida-related prosthetic joint infections, highlighting the need for standardized guidelines and further research.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: January 14th 2025 | Updated: January 17th 2025
Estimating the AUC for Vancomycin Using Non Trapezoidal Equations
Published: January 10th 2025 | Updated: January 17th 2025
Fighting C difficile Before It Starts: Lopoxy Therapeutics Approach
Published: January 12th 2025 | Updated: January 17th 2025
Respiratory Syncytial Viral Infection: Treatment With Ziresovir in Infants
Published: January 3rd 2025 | Updated: January 17th 2025
NIH Offers Updated Risk Assessment on Avian Influenza
Published: January 2nd 2025 | Updated: January 17th 2025
Clinician Feedback Reports on Antibiotics Shape Usage in Pediatric Inpatients With Pneumonia
